Literature DB >> 3751697

Evaluation of histological appearance of tissues removed by cavitron ultrasonic surgical aspirator (CUSA).

V Malhotra, R Malik, R Gondal, P C Beohar, B Parkash.   

Abstract

Histological appearances of the tissue fragments obtained by cavitron ultrasonic surgical aspirator (CUSA) were studied in 25 cases to determine whether the aspirated tissue could be used for diagnosis. It was found that a definite diagnosis could be made on the tissue removed by this method.

Mesh：

Year:  1986        PMID： 3751697     DOI： 10.1007/bf01401235

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


  5 in total

1.  Evaluation of the histopathology of brain tumor tissue obtained by ultrasonic aspiration.

Authors:  I L Richmond; C A Hawksley
Journal:  Neurosurgery       Date:  1983-10       Impact factor: 4.654

2.  Histological appearances of intracranial biopsies obtained using the Cavitron ultrasonic surgical aspirator.

Authors:  R A Blackie; A Gordon
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

3.  Preliminary experience with ultrasonic aspiration in neurosurgery.

Authors:  E S Flamm; J Ransohoff; D Wuchinich; A Broadwin
Journal:  Neurosurgery       Date:  1978 May-Jun       Impact factor: 4.654

4.  Surgical management of holocord intramedullary spinal cord astrocytomas in children.

Authors:  F Epstein; N Epstein
Journal:  J Neurosurg       Date:  1981-06       Impact factor: 5.115

5.  Surgical approach to large thalamic gliomas.

Authors:  B Prakash
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216
  5 in total
  9 in total

1.  CD133+ niches and single cells in glioblastoma have different phenotypes.

Authors:  Karina Christensen; Henrik Daa Schrøder; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2010-12-24       Impact factor: 4.130

2.  Tumor cells from ultrasonic aspirations of glioblastomas migrate and form spheres with radial outgrowth.

Authors:  Marie E Beckner; Esther P Jane; Brian Jankowitz; Naomi R Agostino; Kevin A Walter; Ronald L Hamilton; Ian F Pollack
Journal:  Cancer Lett       Date:  2007-05-31       Impact factor: 8.679

3.  Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma.

Authors:  Simon K Hermansen; Karina G Christensen; Stine S Jensen; Bjarne W Kristensen
Journal:  J Histochem Cytochem       Date:  2011-04       Impact factor: 2.479

4.  Development of stereotactic mass spectrometry for brain tumor surgery.

Authors:  Nathalie Y R Agar; Alexandra J Golby; Keith L Ligon; Isaiah Norton; Vandana Mohan; Justin M Wiseman; Allen Tannenbaum; Ferenc A Jolesz
Journal:  Neurosurgery       Date:  2011-02       Impact factor: 4.654

5.  CD133 identifies perivascular niches in grade II-IV astrocytomas.

Authors:  Karina Christensen; Henrik D Schrøder; Bjarne W Kristensen
Journal:  J Neurooncol       Date:  2008-07-09       Impact factor: 4.130

6.  Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival.

Authors:  Charlotte Aaberg-Jessen; Karina Christensen; Hanne Offenberg; Annette Bartels; Tanja Dreehsen; Steinbjørn Hansen; Henrik Daa Schrøder; Nils Brünner; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

7.  Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.

Authors:  Jeanette Krogh Petersen; Per Jensen; Mia Dahl Sørensen; Bjarne Winther Kristensen
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

8.  Ex vivo ultrasonic samples of human brain tumors in the molecular era.

Authors:  Alastair J Kirby; José P Lavrador; Istvan Bodi; Francesco Vergani; Ranjeev Bhangoo; Keyoumars Ashkan; Gerald T Finnerty
Journal:  Neurooncol Adv       Date:  2020-02-08

Review 9.  Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole.

Authors:  Cassandra P Griffin; Christine L Paul; Kimberley L Alexander; Marjorie M Walker; Hubert Hondermarck; James Lynam
Journal:  Neurooncol Adv       Date:  2021-11-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.